Proteome alterations of cortex and hippocampus tissues in mice subjected to vitamin A depletion

Journal of Nutritional Biochemistry

Volumn 22, Issue 11, 2011, Pages 1003-1008

  Zhang, Ming ^a,b   Huang, Ke ^a,b   Zhang, Zhao ^a,b   Ji, Baohu ^a,b   Zhu, Hui ^a,b   Zhou, Kejun ^a,b   Li, Yang ^a,b   Yang, Jinglei ^a,b   Sun, Liya ^a,b   Wei, Zhiyun ^a,b   He, Guang ^a,b   Gao, Linghan ^a,c   He, Lin ^a,c   Wan, Chunling ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cytoskeleton; Energy metabolism; Proteomics; Schizophrenia; Vitamin A depletion

Indexed keywords

ACTIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DOPAMINE RECEPTOR; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEASOME; PROTEASOME SUBUNIT BETA TYPE 2; PROTEOME; RETINOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BRAIN CORTEX; CYTOSKELETON; GLYCOLYSIS; HIPPOCAMPUS; MASS SPECTROMETRY; MITOCHONDRION; MOUSE; NEUROTRANSMISSION; NONHUMAN; RETINOL DEFICIENCY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACTINS; ANIMALS; CEREBRAL CORTEX; DIZOCILPINE MALEATE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; NERVE TISSUE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOME; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE; SIGNAL TRANSDUCTION; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VITAMIN A DEFICIENCY;

MUS; RODENTIA;

EID: 80054074998     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.08.012     Document Type: Article

References (39)

1. Malik M.A., Blusztajn J.K., Greenwood C.E. Nutrients as trophic factors in neurons and the central nervous system: role of retinoic acid. J Nutr Biochem 2000, 11:2-13.
2. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 2007, 8:755-765.
3. Carta M., Stancampiano R., Tronci E., Collu M., Usiello A., Morelli M., et al. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience 2006, 139:1163-1172.
4. Zetterstrom R.H., Lindqvist E., Mata de Urquiza A., Tomac A., Eriksson U., Perlmann T., et al. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neuroscience 1999, 11:407-416.
5. Etchamendy N., Enderlin V., Marighetto A., Pallet V., Higueret P., Jaffard R. Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signaling. Behav Brain Res 2003, 145:37-49.
6. Cocco S., Diaz G., Stancampiano R., Diana A., Carta M., Curreli R., et al. Vitamin A deficiency produces spatial learning and memory impairment in rats. Neuroscience 2002, 115:475-482.
7. Krezel W., Ghyselinck N., Samad T.A., Dupé V., Kastner P., Borrelli E., et al. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 1998, 279:863-867.
8. Stancampiano R., Carta M., Fadda F. Vitamin A deficiency affects neither frontocortical acetylcholine nor working memory. NeuroReport 2007, 8:241-243.
9. Misner D.L., Jacobs S., Shimizu Y., de Urquiza A.M., Solomin L., Perlmann T., et al. Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S A 2001, 98:11714-11719.
10. Corcoran J.P., So P.L., Maden M. Disruption of the retinoid signalling pathway causes a deposition of amyloid β in the adult rat brain. Eur J Neurosci 2004, 20:896-902.
11. Husson M., Enderlin V., Delacourte A., Ghenimi N., Alfos S., Pallet V., et al. Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in β-amyloid deposits in the cerebral cortex of vitamin A deprived rats. Neurobiol Dis 2006, 23:1-10.
12. Goodman A.B. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci U S A 1998, 95:7240-7244.
13. Goodman A.B. Microarray results suggest altered transport and lowered synthesis of retinoic acid in schizophrenia. Mol Psychiatry 2005, 10:620-621.
14. Wan C., Yang Y., Li H., La Y., Zhu H., Jiang L., et al. Dysregulation of retinoid transporters expression in body fluids of schizophrenia patients. J Proteome Res 2006, 5:3213-3216.
15. Zhang M., Ji B., Zou H., Shi J., Zhang Z., Li X., et al. Vitamin A depletion alters sensitivity of motor behavior to MK-801 in C57BL/6J mice. Behav Brain Funct 2010, 22:6-7.
16. Swatton J.E., Prabakaran S., Karp N.A., Lilley K.S., Bahn S. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Mol. Psychiatry 2004, 9:128-143.
17. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
18. Zhang M., Wan C., Ji B., Zhang Z., Zhu H., Tian N., et al. Proteome alteration of U251 human astrocytoma cell after inhibiting retinoic acid synthesis. Mol Cell Biochem 2009, 323:185-193.
19. Collins M.O., Husi H., Yu L., Brandon J.M., Anderson C.N., Blackstock W.P., et al. Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem 2006, 97:16-23.
20. Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., Grant S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 2000, 3:661-669.
21. Tice D.A., Szeto W., Soloviev I., Rubinfeld B., Fong S.E., Dugger D.L., et al. Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem 2002, 277:14329-14335.
22. Liu T.X., Zhang J.W., Tao J., Zhang R.B., Zhang Q.H., Zhao C.J., et al. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 2000, 96:1496-1504.
23. Farwell A.P., Leonard J.L. Dissociation of actin polymerization and enzyme inactivation in the hormonal regulation of type II iodothyronine 5'-deiodinase activity in astrocytes. Endocrinology 1992, 131:721-728.
24. Harris M.N., Ozpolat B., Abdi F., Gu S., Legler A., Mawuenyega K.G., et al. Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 2004, 104:1314-1323.
25. Lee H.Y., Walsh G.L., Dawson M.I., Hong W.K., Kurie J.M. All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways. J Biol Chem 1998, 273:7066-7071.
26. Fontán-Gabás L., Oliemuller E., Martínez-Irujo J.J., de Miguel C., Rouzaut A. All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation. FEBS J 2007, 274:498-511.
27. Toyo-oka K., Shionoya A., Gambello M.J., Cardoso C., Leventer R., Ward H.L., et al. 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet 2003, 34:274-285.
28. Samuels I.S., Karlo J.C., Faruzzi A.N., Pickering K., Herrup K., Sweatt J.D., et al. Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J Neurosci 2008, 28:6983-6995.
29. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003, 23:7311-7316.
30. Schroeder J.A., Hummel M., Unterwald E.M. Disruption of G(i/o) protein signaling in the nucleus accumbens results in a D1 dopamine receptor-mediated hyperactivity. Pharmacol Biochem Behav 2004, 79:93-99.
31. Edgar P.F., Douglas J.E., Cooper G.J., Dean B., Kydd R., Faull R.L. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry 2000, 5:85-90.
32. Thompson P.M., Rosenberger C., Qualls C. CSF SNAP-25 in schizophrenia and bipolar illness, a pilot study. Neuropsychopharmacology 1999, 21:717-722.
33. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004, 9:684-697. 643.
34. Sun X., Wang J.F., Tseng M., Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 2006, 31:189-196.
35. Vawter M.P., Thatcher L., Usen N., Hyde T.M., Kleinman J.E., Freed W.J. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:571-578.
36. Ishiguro K. Involvement of tau protein kinase in amyloid-beta-induced neurodegeneration. Rinsho Byori 1998, 46:1003-1007.
37. Venezia V., Nizzari M., Repetto E., Violani E., Corsaro A., Thellung S., et al. Amyloid precursor protein modulates ERK-1 and -2 signaling. Ann N Y Acad Sci 2006, 1090:455-465.
38. Luthi-Carter R., Strand A., Peters N.L., Solano S.M., Hollingsworth Z.R., Menon A.S., et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet 2000, 9:1259-1271.
39. Smith R., Klein P., Koc-Schmitz Y., Waldvogel H.J., Faull R.L., Brundin P. Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. J Neurochem 2007, 103:115-123.